NEW YORK (TheStreet) -- CHANGE IN RATINGS
Ariad (ARIA) was downgraded at Chardan to neutral from buy. Valuation call, based on a 12-month price target of $9, Chardan said.
Brookfield Renewable Energy Partners (BEP) was initiated with a sell rating at TheStreet Ratings.
Dreamworks (DWA - Get Report) was downgraded at Piper Jaffray to underweight from neutral. Twelve-month price target is $19. Company offered lower slate expectations.
EP Energy (EPE) was initiated at UBS with a buy rating. Driven by above-average liquids-driven production growth and exposure to Eagle Ford Shale and Midland Basin, UBS said. Twelve-month price target is $25.
Glacier Bancorp (GBCI) was upgraded at DA Davidson to buy from neutral. Twelve-month price target is $33. Estimates were also increased, given better loan and margin trends, DA Davidson said.
CHC (HELI) was initiated at UBS with a buy rating. Offers leverage to attractive long-term growth in offshore markets, UBS said. Twelve-month price target is $13.
Halcon (HK) was downgraded at RBC Capital to sector perform from outperform. Twelve-month price target is $4. Company's leverage profile is concerning, RBC Capital said.
Intermune (ITMN) was downgraded at Leerink Swann to market perform from outperform. Valuation call, based on a 12-month price target of $41, Leerink Swann said.
Jazz Pharmaceuticals (JAZZ) was downgraded at Cantor Fitzgerald to hold. Twelve-month price target is $182. See more risks with the FDA for Xyrem, Cantor said.
LinkedIn (LNKD - Get Report) was upgraded at RBC Capital to outperform from sector perform. Twelve-month price target is $250. Valuation call, as the stock is down 13% over the past six months, RBC Capital said.
Masco (MAS) was upgraded at Keybanc to hold from underweight. Company's execution has steadied, Keybanc said.